CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF)
CUSIP: G1933S101
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Ordinary Shares
- Shares outstanding
- 35,821,764
- Total 13F shares
- 2,658,168
- Share change
- +6,120
- Total reported value
- $7,523,090
- Price per share
- $2.83
- Number of holders
- 22
- Value change
- -$53,802
- Number of buys
- 3
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP G1933S101?
CUSIP G1933S101 identifies CASIF - CASI Pharmaceuticals, Inc. - Ordinary Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP G1933S101:
Top shareholders of CASIF - CASI Pharmaceuticals, Inc. - Ordinary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VR Adviser, LLC |
13F
|
Company |
2.8%
|
987,259
|
$6,081,515 | — | 30 Sep 2024 | |
| Wellington Shields Capital Management, LLC |
13F
|
Company |
0.25%
|
89,217
|
$549,577 | — | 30 Sep 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.18%
|
64,835
|
$399,384 | — | 30 Sep 2024 | |
| Wellington Shields & Co., LLC |
13F
|
Company |
0.12%
|
43,091
|
$265,441 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.12%
|
41,500
|
$255,640 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.09%
|
30,532
|
$188,077 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.06%
|
22,714
|
$135,375 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
19,363
|
$115,403 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.04%
|
14,681
|
$90,435 | — | 30 Sep 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.02%
|
6,900
|
$43,000 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,440
|
$8,870 | — | 30 Sep 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
506
|
$3,117 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0%
|
296
|
$1,823 | — | 30 Sep 2024 | |
| WEST PACES ADVISORS INC. |
13F
|
Company |
0%
|
100
|
$616 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
28
|
$172 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
25
|
$149 | — | 30 Sep 2024 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
13
|
$80 | — | 30 Sep 2024 | |
| Colonial Trust Co / SC |
13F
|
Company |
0%
|
11
|
$68 | — | 30 Sep 2024 | |
| TRUST CO OF VERMONT |
13F
|
Company |
0%
|
10
|
$62 | — | 30 Sep 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
8
|
$49 | — | 30 Sep 2024 |
Institutional Holders of CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF) as of Q4 2024
As of 31 Dec 2024,
CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,658,168 shares.
The largest 10 holders included
Foresite Capital Management VI LLC, VR Adviser, LLC, Woodline Partners LP, Wellington Shields Capital Management, LLC, ADAR1 Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, Wellington Shields & Co., LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, and Royal Bank of Canada.
This page lists
22
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
20
Q4 2024 holders
22
Holder diff
2
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.